133 related articles for article (PubMed ID: 8701927)
1. DNA ploidy, cell cycle kinetics, and low versus high grade atypia in endometrial hyperplasia.
Michael H; Kotylo PK; Mohr M; Roth LM
Am J Clin Pathol; 1996 Jul; 106(1):22-8. PubMed ID: 8701927
[TBL] [Abstract][Full Text] [Related]
2. DNA ploidy and S-phase fraction analyses of hyperplastic, atypical and cancerous endometrium using flow cytometry from paraffin-embedded tissues.
Pervez S; Hitchcock A; Sinton TM; Mani A; Smith JL
Pathol Res Pract; 2002; 198(1):13-7. PubMed ID: 11866205
[TBL] [Abstract][Full Text] [Related]
3. Can flowcytometric DNA studies forecast the prognosis of endometrial hyperplasia?
Sherif LS; Totongy M; Tawfeek M; Abdel-Ghafar H; Badawy AM
Eur J Obstet Gynecol Reprod Biol; 2005 Sep; 122(1):104-6. PubMed ID: 16154045
[TBL] [Abstract][Full Text] [Related]
4. Digital morphometry of cytologic aspirate endometrial samples.
Mahovlić V; Ovanin-Rakić A; Skopljanac-Macina L; Barisić A; Rajhvajn S; Juric D; Projić IS; Ilić-Forko J; Babić D; Skrablin-Kucić S; Bozikov J
Coll Antropol; 2010 Mar; 34(1):45-51. PubMed ID: 20437635
[TBL] [Abstract][Full Text] [Related]
5. Expression of the retinoblastoma-related gene Rb2/p130 is downregulated in atypical endometrial hyperplasia and adenocarcinoma.
Susini T; Massi D; Paglierani M; Masciullo V; Scambia G; Giordano A; Amunni G; Massi G; Taddei GL
Hum Pathol; 2001 Apr; 32(4):360-7. PubMed ID: 11331952
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometry (FCM) analysis of endometrial hyperplasia and carcinoma.
Kysela B; Siracký J; Redecha M; Bárdos A
Neoplasma; 1990; 37(5):489-95. PubMed ID: 2234210
[TBL] [Abstract][Full Text] [Related]
7. Flow cytometric DNA analysis of abnormal endometrium.
Sato S; Tanoguchi K; Tase T; Yajima A
Tohoku J Exp Med; 1996 Feb; 178(2):199-202. PubMed ID: 8727701
[TBL] [Abstract][Full Text] [Related]
8. Ploidy disturbances in endometrial and ovarian carcinomas. A review.
Iversen OE; Laerum OD
Anal Quant Cytol Histol; 1985 Dec; 7(4):327-36. PubMed ID: 3911973
[TBL] [Abstract][Full Text] [Related]
9. bcl-2 is down-regulated in atypical endometrial hyperplasia and adenocarcinoma.
Henderson GS; Brown KA; Perkins SL; Abbott TM; Clayton F
Mod Pathol; 1996 Apr; 9(4):430-8. PubMed ID: 8729985
[TBL] [Abstract][Full Text] [Related]
10. Potential of the learning vector quantizer in the cell classification of endometrial lesions in postmenopausal women.
Karakitsos P; Kyroudes A; Pouliakis A; Stergiou EB; Voulgaris Z; Kittas C
Anal Quant Cytol Histol; 2002 Feb; 24(1):30-8. PubMed ID: 11865947
[TBL] [Abstract][Full Text] [Related]
11. DNA ploidy, cell proliferation and steroid hormone receptors in endometrial hyperplasia and early adenocarcinoma.
Punnonen R; Mattila J; Kuoppala T; Koivula T
J Cancer Res Clin Oncol; 1993; 119(7):426-9. PubMed ID: 8491764
[TBL] [Abstract][Full Text] [Related]
12. [Flow cytometric DNA analysis of uterine endometrial carcinoma].
Izumi S; Yamaoka K; Arai H; Watanabe T; Tsutsui F; Tamura S; Nozawa S; Kurihara S
Nihon Sanka Fujinka Gakkai Zasshi; 1991 Jul; 43(7):722-8. PubMed ID: 1890350
[TBL] [Abstract][Full Text] [Related]
13. Molecular analysis of endometrial hyperplasia in HNPCC-suspicious patients may predict progression to endometrial carcinoma.
Sutter C; Dallenbach-Hellweg G; Schmidt D; Baehring J; Bielau S; von Knebel Doeberitz M; Gebert J
Int J Gynecol Pathol; 2004 Jan; 23(1):18-25. PubMed ID: 14668545
[TBL] [Abstract][Full Text] [Related]
14. Papillary proliferation of the endometrium: a clinicopathologic study of 59 cases of simple and complex papillae without cytologic atypia.
Ip PP; Irving JA; McCluggage WG; Clement PB; Young RH
Am J Surg Pathol; 2013 Feb; 37(2):167-77. PubMed ID: 23211295
[TBL] [Abstract][Full Text] [Related]
15. Risk of subsequent endometrial carcinoma associated with endometrial intraepithelial neoplasia classification of endometrial biopsies.
Lacey JV; Mutter GL; Nucci MR; Ronnett BM; Ioffe OB; Rush BB; Glass AG; Richesson DA; Chatterjee N; Langholz B; Sherman ME
Cancer; 2008 Oct; 113(8):2073-81. PubMed ID: 18720479
[TBL] [Abstract][Full Text] [Related]
16. Atypical endometrial hyperplasia shares genomic abnormalities with endometrioid carcinoma by comparative genomic hybridization.
Baloglu H; Cannizzaro LA; Jones J; Koss LG
Hum Pathol; 2001 Jun; 32(6):615-22. PubMed ID: 11431716
[TBL] [Abstract][Full Text] [Related]
17. Role of Morphometry and Matrix Metalloproteinase-9 Expression in Differentiating between Atypical Endometrial Hyperplasia and Low Grade Endometrial Adenocarcinoma.
Assaf MI; Abd El-Aal W; Mohamed SS; Yassen NN; Mohamed EA
Asian Pac J Cancer Prev; 2018 Aug; 19(8):2291-2297. PubMed ID: 30139240
[TBL] [Abstract][Full Text] [Related]
18. IMMUNOHISTOCHEMISTRY IN ENDOMETRIAL HYPERPLASIA AND ENDOMETRIAL ADENOCARCINOMA.
Socolov D; Socolov R; Lupascu IA; Rugina V; Gabia O; Garauleanu DM; Carauleanu A
Rev Med Chir Soc Med Nat Iasi; 2016; 120(2):355-62. PubMed ID: 27483717
[TBL] [Abstract][Full Text] [Related]
19. DNA-flow-cytometric measurements on the normal, atrophic, hyperplastic and neoplastic human endometrium.
Feichter GE; Höffken H; Heep J; Haag D; Heberling D; Brandt H; Rummel H; Goerttler K
Virchows Arch A Pathol Anat Histopathol; 1982; 398(1):53-65. PubMed ID: 6819702
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic histologic criteria of atypical adenomatous hyperplasia and well differentiated adenocarcinoma of the endometrium.
Liapis A; Pafitis A; Hassiakos D; Chirakis M; Zourlas PA
Eur J Gynaecol Oncol; 1994; 15(6):464-8. PubMed ID: 7875162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
